Incretin Atlas·MoleculesTrialsOutcomesTimelinePipelineAboutMedical Adviser's Group
Incretin Atlas › Molecules › Danuglipron

Danuglipron

GLP-1 (small molecule) · oral · Pfizer

Data cut 12 November 2026 · page built 16 November 2026 · 0 trial arms · 0 trials with results · 0 registered trials · see on the pipeline board

Summary

Also known as
PF-06882961, Pfizer
Mechanism
GLP-1 (small molecule)
Route
oral
Company
Pfizer
Highest development stage
stopped
Status (as of data cut)
Discontinued (2025, liver safety signal) verify
Next milestone
—

Trial arms: weight, HbA1c and tolerability

No trial arms with extracted efficacy or tolerability data yet.

Primary sources

No source recorded.

How to cite this page

Medical Adviser's Group. Incretin Atlas: Danuglipron. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/danuglipron/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.

Cite the primary publication for any single result; every value above links to it.